Laura Seynaeve

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 177 citations · Full text

Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial

Johnny Duerinck, Julia Katharina Schwarze, Gil Awada et al. · Journal for ImmunoTherapy of Cancer · 2021 · 101 citations · Full text

Optimization of dental CBCT exposures through mAs reduction

Ruben Pauwels, Laura Seynaeve, João César Guimarães Henriques et al. · Dentomaxillofacial Radiology · 2015 · 89 citations · Full text

Accurate detection of typical absence seizures in adults and children using a two‐channel electroencephalographic wearable behind the ears

Lauren Swinnen, Christos Chatzichristos, Katrien Jansen et al. · Epilepsia · 2021 · 69 citations · Full text

Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx)

Gil Awada, Laïla Ben Salama, Jennifer Cremer et al. · Journal for ImmunoTherapy of Cancer · 2020 · 54 citations · Full text